| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/QAD.0B013E328336098C |
| P698 | PubMed publication ID | 20177361 |
| P50 | author | Dermot Kenny | Q37834610 |
| Aaron J Peace | Q43611609 | ||
| Eileen O'Connor | Q61467813 | ||
| P2093 | author name string | John S Lambert | |
| Patrick W G Mallon | |||
| Claudette S Satchell | |||
| Anthony F Tedesco | |||
| Aoife G Cotter | |||
| Gerard J Sheehan | |||
| Andrew Clare | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 649-657 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Platelet function and HIV: a case-control study | |
| P478 | volume | 24 |
| Q84742760 | A clinical cardiology perspective of thrombophilias |
| Q40578438 | Abacavir has no prothrombotic effect on platelets in vitro. |
| Q35072103 | Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients |
| Q36680086 | Cancer prevention in HIV-infected populations |
| Q34793193 | Cardiovascular implications from untreated human immunodeficiency virus infection |
| Q34342368 | Chronic HIV disease and activation of the coagulation system |
| Q57098373 | Clopidogrel discontinuation and platelet reactivity following coronary stenting |
| Q28543075 | Differential adipose tissue gene expression profiles in abacavir treated patients that may contribute to the understanding of cardiovascular risk: a microarray study |
| Q40372167 | HIV infection, ACS, PCI and high platelet reactivity: ingredients for a perfect thrombotic storm |
| Q35989740 | HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction |
| Q33393202 | HIV-1 Tat-induced platelet activation and release of CD154 contribute to HIV-1-associated autoimmune thrombocytopenia |
| Q38603237 | Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy |
| Q99553294 | Increased levels of reactive oxygen species in platelets and platelet-derived microparticles and the risk of respiratory failure in HIV/AIDS patients |
| Q57098021 | Increased platelet reactivity in HIV-1-infected patients receiving abacavir-containing antiretroviral therapy |
| Q36578046 | Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir |
| Q41436325 | Initial Presentation of HIV Infection With Two Successive Acute Arterial Thromboses: A Case Report |
| Q35643573 | Management of dyslipidemia in HIV-infected patients |
| Q36377944 | Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV. |
| Q33827624 | Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection |
| Q28550869 | Modeling HIV-1 Induced Neuroinflammation in Mice: Role of Platelets in Mediating Blood-Brain Barrier Dysfunction |
| Q28548326 | Platelet Activation in Human Immunodeficiency Virus Type-1 Patients Is Not Altered with Cocaine Abuse |
| Q96645360 | Platelet Gene Expression and Function in COVID-19 Patients |
| Q59355656 | Platelet Transcriptome Profiling in HIV and ATP-Binding Cassette Subfamily C Member 4 (ABCC4) as a Mediator of Platelet Activity |
| Q33403375 | Role of CD61+ cells in thrombocytopenia of dengue patients |
| Q40680369 | Short-term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F2α in HIV-1 patients on abacavir-based therapies |
| Q41140041 | The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV-1 infection. |
| Q42218493 | The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection |
| Q35785698 | Thromboelastography on plasma reveals delayed clot formation and accelerated clot lyses in HIV-1 infected persons compared with healthy controls |
Search more.